您使用的浏览器不受支持。
本网站的某些功能可能无法正常运行。为获得最佳的用户体验,请使用Chrome、Firefox、Safari或Edge浏览本网站。

COVID-19 更新

Repligen responds to COVID-19: Operations Status

Repligen理解并支持我们的客户在生物药、疫苗和诊断试剂开发和生产中所扮演的重要角色。作为一家公司,我们关注员工的健康和安全,以及为我们的全球客户持续供应我们的产品和服务。

A cross-functional and multi-site COVID-19 Task Force at Repligen continues to monitor and evaluate the evolving global situation. As a team, we are assessing the latest guidance and facts, and are prioritizing decisions that will protect our employees and ensure that our manufacturing facilities remain open.  If you have specific questions or concerns regarding product supply or technology support, please contact your local Account Manager or our Customer Service team.

 
November 23, 2020 Update

Monitoring and Securing Supply Chain

We have assessed our raw material and finished good inventory positions across all products and have sufficient quantity on hand to manufacture against current and future demand.  All products are available within stated lead times and we do not anticipate shortages or delays at this time.

Manufacturing and Operational Status

To date, our manufacturing facilities and distribution centers are fully operational.  We have recently implemented site visitor restrictions, work from home policies for non-operational staff, enhanced facility cleaning procedures, work cell optimization and personal hygiene training to ensure the protection of our employees, manufacturing centers and distribution networks.  These approaches reduce risk of interruption at our manufacturing centers of excellence and distribution centers.

Commercial and Technical Support

We understand that many of our customers are asking us to restrict non-essential visits. Our customer-facing teams are available and enabled to take orders, answer inquiries, and provide support remotely or in person, as allowed, if the situation requires such support. We have defined our global employee travel guidelines to support all customer facing activities.

Employee and Facility Safety

We are implementing precautionary measures to help protect employees and visitors to our sites.  Visitors will be notified of required procedures prior to arriving to a site.  Signage at entry ways indicate visitor restrictions and procedures.  We have implemented temperature screening for all individuals entering our sites. We have also implemented employee travel restrictions to all High-risk Level locations (as defined by the CDC) and a self-isolation decision tree to handle travel and potential exposure situations.